The E36-generation BMW M3 tends to get overlooked. Not this one. Lightened with carbon fiber and imbued with more than 300 horsepower from its naturally aspirated straight-six engine, it's a Group A ...
Australia's CSL, which earlier this year paused plans to put its CSL Seqirus vaccine division up for sale, has opened the doors to a new $1 billion cell-based influenza vaccine and antivenom ...
Three years after introducing Hemgenix, the first gene therapy for hemophilia B, CSL Behring has released long-term data proving the treatment’s benefits remain durable after five years. The five-year ...
A leading investment expert says ASX investors have a rare chance to buy CSL shares at a discount. CSL shares remain down 35.2% over the past year, impacted by concerns over vaccine sales and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback